For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220722:nRSV3642Ta&default-theme=true
RNS Number : 3642T Cambridge Cognition Holdings PLC 22 July 2022
22 July 2022
Cambridge Cognition Holdings Plc
("Cambridge Cognition", the "Company" or the "Group")
Director/PDMR Share Purchases
Cambridge Cognition Holdings Plc (AIM: COG), which develops and markets
digital solutions to assess brain health, was informed on 21 July 2022 of the
following purchases of the Company's ordinary shares by Directors and PDMRs of
the Company.
The purchases made on 21 July 2022 are detailed in the table below:
Director/PDMR No. of Ordinary Shares purchased Purchase price per Ordinary Share Total no. of Ordinary Shares held Percentage ownership of total issued share capital
Matthew Stork 22,950 £1.13 147,950 0.47%
Stephen Symonds 22,950 £1.13 22,950 0.07%
Further information on the purchases is contained in the disclosure tables
below.
The information contained within this announcement is deemed by the Company to
constitute inside information stipulated under the Market Abuse Regulation
(EU) No. 596/2014 as it forms part of UK domestic law by virtue of the
European Union (Withdrawal) Act 2018. Upon the publication of this
announcement via the Regulatory Information Service, this inside information
is now considered to be in the public domain.
For further information, please contact:
Cambridge Cognition Holdings Plc Tel: 01223 810 700
Matthew Stork, Chief Executive Officer press@camcog.com
Stephen Symonds, Chief Financial Officer
Panmure Gordon (UK) Ltd
(NOMAD and Joint Broker) Tel: 020 78862500
Freddy Crossley / Emma Earl / Mark Rodgers (Corporate Advisory)
Rupert Dearden (Corporate Broking)
Dowgate Capital Limited (Joint Broker) Tel: 020 3903 7715
David Poutney / James Serjeant
IFC Advisory Ltd (Financial PR and IR) Tel: 020 3934 6630
Tim Metcalfe / Graham Herring / Zach Cohen cog@investor-focus.co.uk
Notes to Editors
About Cambridge Cognition
Cambridge Cognition is a technology company developing digital health products
to better understand, detect and treat conditions affecting brain health. The
Company's software products assess cognitive health in patients worldwide to
improve clinical trial outcomes, identify and stratify patients early and
improve global efficiency in pharmaceutical and healthcare industries.
For further information visit www.cambridgecognition.com
(http://www.cambridgecognition.com/)
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING
MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM:
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Matthew Stork
2 Reason for the notification
a) Position/status Chief Executive Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Cambridge Cognition Holdings Plc
b) LEI 213800SZKDIN122EPA96
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 0.01p each
Identification code
GB00B8DV9647
b) Nature of the transaction Purchase of Shares
c) Price(s) and volume(s) Price(s) Volume(s)
£1.13 22,950
d) Aggregated information 22,950
- Aggregated volume £1.13
- Price
e) Date of the transaction 21 July 2022
f) Place of the transaction London Stock Exchange
d)
Aggregated information
- Aggregated volume
- Price
22,950
£1.13
e)
Date of the transaction
21 July 2022
f)
Place of the transaction
London Stock Exchange
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Stephen Symonds
2 Reason for the notification
a) Position/status Chief Financial Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Cambridge Cognition Holdings Plc
b) LEI 213800SZKDIN122EPA96
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 0.01p each
Identification code
GB00B8DV9647
b) Nature of the transaction Purchase of Shares
c) Price(s) and volume(s) Price(s) Volume(s)
£1.13 22,950
d) Aggregated information 22,950
- Aggregated volume £1.13
- Price
e) Date of the transaction 21 July 2022
f) Place of the transaction London Stock Exchange
d)
Aggregated information
- Aggregated volume
- Price
22,950
£1.13
e)
Date of the transaction
21 July 2022
f)
Place of the transaction
London Stock Exchange
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHPPURWMUPPGQG